Stabilizing Slow-Wave Sleep

Restorative sleep depends not only on depth, but on the stability of slow-wave sleep and the neural timing that sustains it.

Kunasan develops non-invasive neuromodulation technology designed to support slow-wave sleep continuity through modulation of distributed spinal–autonomic and sleep regulatory networks

Restoring Brain Sleep Timing

Clinical Research Shows 

  • 72% reduction in sleep fragmentation
  • 36% increase in slow-wave sleep duration
  • 42% increase in slow-wave sleep proportion

Latest News

June 2025

Clinical Trial Shows Kunasan Technology Increases Deep Sleep in Adults with Insomnia

March 2025

Dr. Dan Gartenberg Joins Kunasan Inc as Chief Scientist
An Experienced Leader in Sleep Research

About Kunasan

Kunasan is a Colorado-based neurotechnology company developing non-invasive sleep neuromodulation platforms designed to support healthy sleep architecture and coordinated autonomic regulation during sleep.

Our technology delivers gentle, non-contact electromagnetic modulation during sleep designed to support coordinated autonomic and thalamocortical network dynamics associated with slow-wave sleep continuity, recovery biology, and restorative nighttime physiology.

Many neurological diseases are diagnosed and treated after substantial pathology has already accumulated. Our focus is to investigate whether supporting sleep restoration and recovery biology earlier in the disease continuum may contribute to long-term brain resilience through scalable home-based approaches.

Our Mission

To develop safe, accessible neuromodulation technologies that support sleep restoration and recovery biology through coordinated network regulation during sleep.

Through clinical validation and responsible innovation, we aim to advance cognitive health, neurological resilience, and healthy aging.

Kunasan logo blue

Meet The Team

Paul Mawson
Chief Executive Officer

Paul Mawson

Paul Mawson CEO & Co-founder of Kunasan Inc has amassed 30+  years’ experience in the semiconductor industry. He is a natural entrepreneur, engineer, and business leader with a dual focus on neurological dysfunction treatment and optimizing performance and recovery. Paul is named on 7 USPTO issued patents.

Chief Scientist

Dan Gartenberg, PhD

-- Adjunct Faculty in Biobehavioral Health at Penn State.
-- Leads STTR/SBIR-funded projects developing technologies to measure and improve sleep.
-- Former Engineering Psychologist at the Naval Research Lab, where he applied AI and cognitive models to understand fatigue and human performance 2009-2015.
-- Recognized as a Distinguished Alumni in Psychology by the University of Wisconsin 2022.

Scientific Advisor

Jo M. Solet, MS, EdM, PhD, OTR/L

-- Assistant Professor of Medicine at Harvard Medical School.
-- Member of the Harvard Medical School. Division of Sleep Medicine and the Department of Medicine at Cambridge Health Alliance.
-- Dr. Solet led a significant research study funded by multiple grants investigating noise and its impact on patient sleep disruption in hospital settings.
-- She has also held roles such as Faculty Chair of the Harvard Medical School/Harvard School of Dental Medicine Joint Committee on the Status of Women (JCSW) and contributed to The Harvard University Task Force on Women in Science and Engineering.

Learn More About

OUR PRODUCTS

FREQUEN-ZZZ

FREQUEN-ZZZ® is an investigational sleep neuromodulation platform designed to support coordinated spinal–autonomic network regulation during sleep

DeltaWave TVMS

DeltaWave TVMS is an investigational neuromodulation platform under clinical evaluation for its ability to support sleep restoration through distributed autonomic network modulation.

Talk to us

Have any questions or would like to get in touch? Email us at [email protected] or write us a message below and we will get back to you shortly.


Scroll to Top